• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康科学中的不准确沟通:以疟疾治疗中“部分青蒿素抗性”为例。

Inaccurate communication in health sciences: The case of 'partial artemisinin resistance' for the treatment of malaria.

作者信息

Hanscheid T, Mahomed Sara M, Rebelo Maria, Henriques Susana Oliveira, Grobusch Martin P

机构信息

Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.

Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Location AMC, Amsterdam Infection & Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, the Netherlands.

出版信息

New Microbes New Infect. 2024 Nov 30;62:101544. doi: 10.1016/j.nmni.2024.101544. eCollection 2024 Dec.

DOI:10.1016/j.nmni.2024.101544
PMID:39719945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11667688/
Abstract

BACKGROUND

Accurate scientific terminology is crucial in health sciences to avoid misinterpretations. The use of 'artemisinin resistance' to describe delayed parasite clearance may be inaccurately equated with full resistance, as is typically the case when 'resistance' is used with other pathogens, leading to potential confusion. In 2018, the World Health Organization (WHO) introduced 'partial artemisinin resistance' to more accurately reflect the delayed parasite clearance observed with artemisinin-based therapies.

METHODS

We analyzed whether articles in PubMed accurately convey the concept of 'partial artemisinin resistance' using GPT-4 to generate related search terms. AntConc was employed for corpus analysis of retrieved articles to examine terminology in titles and abstracts. A manual review evaluated the use of the WHO concept of 'partial artemisinin resistance' in the full text of a subset of high-impact articles.

RESULTS

Out of 4041 articles retrieved, only 7 % (n = 281) used 'partial' or 'delayed' in titles or abstracts. Even after 2018, when WHO introduced the term 'partial artemisinin resistance', only 10 % of articles included this. Manual analysis of 161 full-text articles revealed that 94 % did not use 'partial artemisinin resistance', and 59 % did not explain the concept of delayed parasite clearance.

CONCLUSION

The delayed introduction of the term 'partial artemisinin resistance' may have contributed to continued use of the scientifically questionable term 'artemisinin resistance'. This term may be misunderstood as full resistance, as is common with antibiotic resistance. Accurate terminology is essential for clear scientific communication, and precise terms should be established and consistently used from the outset by scientists and clinicians.

摘要

背景

准确的科学术语在健康科学领域至关重要,可避免误解。用“青蒿素抗性”来描述寄生虫清除延迟可能会被不准确地等同于完全抗性,这与“抗性”用于其他病原体时的典型情况相同,从而导致潜在的混淆。2018年,世界卫生组织(WHO)引入了“部分青蒿素抗性”,以更准确地反映基于青蒿素疗法所观察到的寄生虫清除延迟情况。

方法

我们使用GPT-4生成相关搜索词,分析了PubMed上的文章是否准确传达了“部分青蒿素抗性”这一概念。利用AntConc对检索到的文章进行语料库分析,以检查标题和摘要中的术语。人工评审评估了高影响力文章子集中的全文对WHO“部分青蒿素抗性”概念的使用情况。

结果

在检索到的4041篇文章中,只有7%(n = 281)在标题或摘要中使用了“部分”或“延迟”。即使在2018年WHO引入“部分青蒿素抗性”一词之后,也只有10%的文章提及了这一概念。对161篇全文文章的人工分析显示,94%的文章未使用“部分青蒿素抗性”,59%的文章未解释寄生虫清除延迟的概念。

结论

“部分青蒿素抗性”一词引入较晚,可能导致了科学上有问题的术语“青蒿素抗性”的持续使用。这个术语可能会被误解为完全抗性,就像抗生素抗性那样常见。准确的术语对于清晰的科学交流至关重要,科学家和临床医生应从一开始就建立并始终使用精确的术语。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8d7/11667688/6e0867f6072c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8d7/11667688/686331cf0043/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8d7/11667688/69ed6dbef76b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8d7/11667688/6e0867f6072c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8d7/11667688/686331cf0043/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8d7/11667688/69ed6dbef76b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8d7/11667688/6e0867f6072c/gr3.jpg

相似文献

1
Inaccurate communication in health sciences: The case of 'partial artemisinin resistance' for the treatment of malaria.健康科学中的不准确沟通:以疟疾治疗中“部分青蒿素抗性”为例。
New Microbes New Infect. 2024 Nov 30;62:101544. doi: 10.1016/j.nmni.2024.101544. eCollection 2024 Dec.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Unpacking 'Artemisinin Resistance'.解析“青蒿素抗药性”。
Trends Pharmacol Sci. 2017 Jun;38(6):506-511. doi: 10.1016/j.tips.2017.03.007. Epub 2017 May 2.
4
Cambodian parasites with reduced hemoglobin digestion display delayed clearance upon artesunate treatment.血红蛋白消化能力降低的柬埔寨寄生虫在青蒿琥酯治疗后清除延迟。
medRxiv. 2025 Mar 11:2025.03.09.25323469. doi: 10.1101/2025.03.09.25323469.
5
Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy.抗疟药物耐药性的反教条方法:用青蒿素联合疗法重新评估治疗失败。
Trends Parasitol. 2013 Jul;29(7):313-7. doi: 10.1016/j.pt.2013.04.001. Epub 2013 Apr 25.
6
Emerging threat of artemisinin partial resistance markers (pfk13 mutations) in Plasmodium falciparum parasite populations in multiple geographical locations in high transmission regions of Uganda.在乌干达高传播地区的多个地理位置,疟原虫寄生虫种群中出现了青蒿素部分耐药性标记(pfk13 突变)的新威胁。
Malar J. 2024 Nov 5;23(1):330. doi: 10.1186/s12936-024-05158-9.
7
How "resistant" is artemisinin resistant malaria? - The risks of ambiguity using the term "resistant" malaria.青蒿素耐药疟疾的“耐药性”有多高?——使用“耐药性”疟疾一词存在歧义的风险。
Travel Med Infect Dis. 2018 Jul-Aug;24:23-24. doi: 10.1016/j.tmaid.2018.04.008. Epub 2018 Apr 30.
8
Artemisinin resistance in Plasmodium falciparum: what is it really?疟原虫对青蒿素的抗药性:它到底是什么?
Trends Parasitol. 2013 Jul;29(7):318-20. doi: 10.1016/j.pt.2013.05.002. Epub 2013 Jun 11.
9
How a GPT-aided survey reveals a medical student's misunderstanding of the term 'artemisinin resistance'.一项由GPT辅助的调查如何揭示一名医学生对“青蒿素耐药性”一词的误解。
New Microbes New Infect. 2024 Dec 5;63:101552. doi: 10.1016/j.nmni.2024.101552. eCollection 2025 Feb.
10
Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.青蒿素类抗疟药作用机制的思考:第1部分——“碳自由基”和“血红素”假说
Infect Disord Drug Targets. 2013 Aug;13(4):217-77. doi: 10.2174/1871526513666131129155708.

引用本文的文献

1
How a GPT-aided survey reveals a medical student's misunderstanding of the term 'artemisinin resistance'.一项由GPT辅助的调查如何揭示一名医学生对“青蒿素耐药性”一词的误解。
New Microbes New Infect. 2024 Dec 5;63:101552. doi: 10.1016/j.nmni.2024.101552. eCollection 2025 Feb.

本文引用的文献

1
Artemisinin-resistant malaria.抗青蒿素疟疾
Clin Microbiol Rev. 2024 Dec 10;37(4):e0010924. doi: 10.1128/cmr.00109-24. Epub 2024 Oct 15.
2
How, and why, science and health researchers read scientific (IMRAD) papers.科学和健康研究人员如何以及为何阅读科学(IMRAD)论文。
PLoS One. 2024 Jan 22;19(1):e0297034. doi: 10.1371/journal.pone.0297034. eCollection 2024.
3
Disseminating health research to public health policy-makers and practitioners: a survey of source, message content and delivery modality preferences.
向公共卫生政策制定者和从业者传播健康研究:对来源、信息内容和传递方式偏好的调查。
Health Res Policy Syst. 2023 Nov 27;21(1):121. doi: 10.1186/s12961-023-01066-7.
4
Responsible dissemination of health and medical research: some guidance points.健康与医学研究的责任传播:一些指导要点。
BMJ Evid Based Med. 2023 Jun;28(3):144-147. doi: 10.1136/bmjebm-2022-111967. Epub 2022 Sep 2.
5
The Use of Social Media for Dissemination of Research Evidence to Health and Social Care Practitioners: Protocol for a Systematic Review.利用社交媒体向健康与社会护理从业者传播研究证据:一项系统评价方案
JMIR Res Protoc. 2023 May 12;12:e45684. doi: 10.2196/45684.
6
Malaria Parasite Clearance: What Are We Really Measuring?疟疾寄生虫清除:我们真正在测量什么?
Trends Parasitol. 2020 May;36(5):413-426. doi: 10.1016/j.pt.2020.02.005. Epub 2020 Mar 21.
7
Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents.抗菌药物耐药性和新型抗菌药物时代的尿路感染治疗。
Postgrad Med. 2020 Apr;132(3):234-250. doi: 10.1080/00325481.2019.1680052. Epub 2019 Oct 24.
8
Recent updates on drug resistance in Mycobacterium tuberculosis.结核分枝杆菌耐药性的最新研究进展。
J Appl Microbiol. 2020 Jun;128(6):1547-1567. doi: 10.1111/jam.14478. Epub 2019 Oct 29.
9
Point-Counterpoint: Differences between the European Committee on Antimicrobial Susceptibility Testing and Clinical and Laboratory Standards Institute Recommendations for Reporting Antimicrobial Susceptibility Results.观点对质:欧洲抗菌药物敏感性试验委员会与临床和实验室标准协会关于报告抗菌药物敏感性试验结果的推荐意见之间的差异。
J Clin Microbiol. 2019 Aug 26;57(9). doi: 10.1128/JCM.01129-19. Print 2019 Sep.
10
A Temporizing Solution to "Artemisinin Resistance".针对“青蒿素耐药性”的一种临时解决方案。
N Engl J Med. 2019 May 30;380(22):2087-2089. doi: 10.1056/NEJMp1901233. Epub 2019 Apr 24.